Eli Lilly's New Injection Delivers Twice the Weight Loss of Leading Competitor

Indianapolis, Wednesday, 28 October 2026.
Eli Lilly’s experimental drug retatrutide helped diabetes patients lose up to 21.5 kilograms—more than double the reduction seen with Ozempic—by activating three distinct metabolic hormones simultaneously.